COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 08/09/23
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 08/09/23
CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration AgreementPRNewsWire • 06/26/23
CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate UpdatePRNewsWire • 05/24/23
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 05/02/23
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and OrgansBusiness Wire • 04/04/23
Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate UpdatePRNewsWire • 03/29/23
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 03/14/23
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of ObjectivesPRNewsWire • 01/04/23
CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder FormPRNewsWire • 01/03/23
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial ResultsPRNewsWire • 12/01/22
CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative ColitisPRNewsWire • 11/15/22
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90PRNewsWire • 11/07/22
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17PRNewsWire • 11/03/22
CollPlant to present at the Dawson James Small Cap Growth Conference on October 12PRNewsWire • 10/03/22
CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, ItalyPRNewsWire • 09/19/22
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial ResultsPRNewsWire • 08/25/22
CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine StudyPRNewsWire • 06/29/22
CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial ResultsPRNewsWire • 05/26/22
CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and ScreeningPRNewsWire • 04/25/22